SG163517A1 - Antiviral compounds and methods - Google Patents
Antiviral compounds and methodsInfo
- Publication number
- SG163517A1 SG163517A1 SG201004454-3A SG2010044543A SG163517A1 SG 163517 A1 SG163517 A1 SG 163517A1 SG 2010044543 A SG2010044543 A SG 2010044543A SG 163517 A1 SG163517 A1 SG 163517A1
- Authority
- SG
- Singapore
- Prior art keywords
- methods
- antiviral compounds
- relates
- mammals
- therapeutic
- Prior art date
Links
- 230000000840 anti-viral effect Effects 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 241000124008 Mammalia Species 0.000 abstract 1
- 208000036142 Viral infection Diseases 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 230000009385 viral infection Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
- C07C279/22—Y being a hydrogen or a carbon atom, e.g. benzoylguanidines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/69—Two or more oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/06—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/22—Radicals substituted by doubly bound hetero atoms, or by two hetero atoms other than halogen singly bound to the same carbon atom
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Furan Compounds (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2005903360A AU2005903360A0 (en) | 2005-06-24 | Anti-viral compounds and methods |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG163517A1 true SG163517A1 (en) | 2010-08-30 |
Family
ID=37570036
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG201004454-3A SG163517A1 (en) | 2005-06-24 | 2006-06-23 | Antiviral compounds and methods |
Country Status (16)
| Country | Link |
|---|---|
| US (3) | US8669280B2 (fr) |
| EP (2) | EP1902017B1 (fr) |
| JP (2) | JP5373392B2 (fr) |
| KR (2) | KR101419327B1 (fr) |
| CN (2) | CN103274970B (fr) |
| AU (1) | AU2006261593B2 (fr) |
| BR (2) | BRPI0612309B8 (fr) |
| CA (1) | CA2612403C (fr) |
| DK (2) | DK2826770T3 (fr) |
| ES (2) | ES2491217T3 (fr) |
| NZ (3) | NZ596107A (fr) |
| PL (2) | PL2826770T3 (fr) |
| PT (2) | PT2826770T (fr) |
| SG (1) | SG163517A1 (fr) |
| WO (1) | WO2006135978A1 (fr) |
| ZA (1) | ZA200800256B (fr) |
Families Citing this family (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0411900B8 (pt) * | 2003-06-26 | 2021-05-25 | Biotron Ltd | compostos e composições farmacêuticas compreendendo os mesmos |
| PT2826770T (pt) * | 2005-06-24 | 2018-12-18 | Biotron Ltd | Compostos acilguanidinas com atividade antiviral |
| EP2148678A4 (fr) | 2007-05-23 | 2010-08-04 | Siga Technologies Inc | Médicaments antiviraux pour le traitement et la prévention d'une infection par la dengue |
| WO2009018609A1 (fr) * | 2007-08-03 | 2009-02-12 | Biotrom Limited | Compositions et procédés antivirus de l'hépatite c |
| AU2013219202B2 (en) * | 2007-08-03 | 2016-12-08 | Biotron Limited | Hepatitis C antiviral compositions and methods |
| JP5569857B2 (ja) * | 2007-08-10 | 2014-08-13 | アステラス製薬株式会社 | 二環式アシルグアニジン誘導体 |
| JPWO2010090305A1 (ja) * | 2009-02-09 | 2012-08-09 | アステラス製薬株式会社 | 置換アシルグアニジン誘導体 |
| EP2394987A4 (fr) * | 2009-02-09 | 2012-09-05 | Astellas Pharma Inc | Dérivé d'acylguanidine |
| TW201116281A (en) | 2009-08-06 | 2011-05-16 | Astellas Pharma Inc | N atom containing ring acylguanidine derivatives |
| ES2524356T3 (es) | 2010-07-22 | 2014-12-05 | Gilead Sciences, Inc. | Métodos y compuestos para tratar infecciones provocadas por virus Paramyxoviridae |
| US9126106B1 (en) | 2010-11-05 | 2015-09-08 | Wms Gaming, Inc. | Promotional content coordination in wagering game machines |
| JP5906253B2 (ja) * | 2010-12-16 | 2016-04-20 | アッヴィ・インコーポレイテッド | 抗ウイルス性化合物 |
| TWI740546B (zh) | 2014-10-29 | 2021-09-21 | 美商基利科學股份有限公司 | 製備核糖苷的方法 |
| HRP20220355T1 (hr) | 2015-09-16 | 2022-05-13 | Gilead Sciences, Inc. | Postupci za liječenje infekcija coronaviridae |
| AU2018218179B2 (en) * | 2017-02-08 | 2023-05-04 | Biotron Limited | Methods of treating influenza |
| CN116036112A (zh) | 2017-03-14 | 2023-05-02 | 吉利德科学公司 | 治疗猫冠状病毒感染的方法 |
| WO2018204198A1 (fr) | 2017-05-01 | 2018-11-08 | Gilead Sciences, Inc. | Formes cristallines de (s) 2 éthylbutyl 2 (((s) (((2r,3s,4r,5r) 5 (4 aminopyrrolo[2,1-f] [1,2,4]triazine-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2 yl)méthoxy)(phénoxy) phosphoryl)amino)propanoate |
| EP4512475A3 (fr) | 2017-07-11 | 2025-05-14 | Gilead Sciences, Inc. | Compositions comprenant un inhibiteur de l'arn polymerase et de la cyclodextrine pour le traitement d'infections virales |
| WO2021102508A1 (fr) * | 2019-11-26 | 2021-06-03 | Biotron Limited | Méthodes de traitement d'une infection par le vih |
| AU2021214911A1 (en) | 2020-01-27 | 2022-07-21 | Gilead Sciences, Inc. | Methods for treating SARS CoV-2 infections |
| CN118994170A (zh) | 2020-03-12 | 2024-11-22 | 吉利德科学公司 | 制备1'-氰基核苷的方法 |
| EP4132651B1 (fr) | 2020-04-06 | 2026-03-18 | Gilead Sciences, Inc. | Formulations d'inhalation d'analogues de carbanucléosides à substitution 1'-cyano |
| ES3041698T3 (en) | 2020-05-29 | 2025-11-13 | Gilead Sciences Inc | Remdesivir for the treatment of viral infections |
| CA3187821A1 (fr) | 2020-06-24 | 2021-12-30 | Gilead Sciences, Inc. | Analogues de 1'-cyano nucleoside et leurs utilisations |
| MX2023002233A (es) | 2020-08-24 | 2023-03-15 | Gilead Sciences Inc | Compuestos fosfolipidos y usos de estos. |
| WO2022047065A2 (fr) | 2020-08-27 | 2022-03-03 | Gilead Sciences, Inc. | Composés et méthodes de traitement d'infections virales |
| TWI811812B (zh) | 2020-10-16 | 2023-08-11 | 美商基利科學股份有限公司 | 磷脂化合物及其用途 |
| WO2022251318A1 (fr) | 2021-05-26 | 2022-12-01 | Gilead Sciences, Inc. | Formulations phospholipidiques d'analogues de carba-nucléoside 1'-cyano-substitué |
| JP7719954B2 (ja) | 2021-08-18 | 2025-08-06 | ギリアード サイエンシーズ， インコーポレイテッド | リン脂質化合物並びにその製造方法及び使用方法 |
| AU2022399231A1 (en) * | 2021-11-24 | 2024-05-23 | Biotron Limited | Methods of treating sars-cov-2 infection |
| EP4486746A1 (fr) | 2022-03-02 | 2025-01-08 | Gilead Sciences, Inc. | Composés et méthodes de traitement d'infections virales |
| TW202525810A (zh) | 2022-03-02 | 2025-07-01 | 美商基利科學股份有限公司 | 用於治療病毒感染的化合物及方法 |
| CR20240367A (es) | 2022-03-03 | 2024-09-30 | Gilead Sciences Inc | Compuestos antivirales y métodos de elaboración y uso de los mismos. |
| WO2023167055A1 (fr) * | 2022-03-03 | 2023-09-07 | 日本曹達株式会社 | Agent antiviral |
| WO2023168254A1 (fr) | 2022-03-03 | 2023-09-07 | Gilead Sciences, Inc. | Composés antiviraux, leurs procédés de production et d'utilisation |
| CN119604286A (zh) | 2022-06-06 | 2025-03-11 | 吉利德科学公司 | 用于治疗包括sars-cov-2的病毒感染的方法 |
| WO2024006376A1 (fr) | 2022-06-29 | 2024-01-04 | Gilead Sciences, Inc. | Formes solides d'un analogue nucléosidique et leurs utilisations |
| WO2024006461A1 (fr) | 2022-06-30 | 2024-01-04 | Gilead Sciences, Inc. | Formes solides d'un analogue nucléosidique et leurs utilisations |
| CN115260100B (zh) * | 2022-08-08 | 2023-12-12 | 赛诺瑞生物医药技术(无锡)有限公司 | 一种用于制备冠状病毒治疗药物的取代酰基胍类化合物和用途 |
| US12357577B1 (en) | 2024-02-02 | 2025-07-15 | Gilead Sciences, Inc. | Pharmaceutical formulations and uses thereof |
| EP4665737A1 (fr) | 2023-02-16 | 2025-12-24 | Gilead Sciences, Inc. | Composés phospholipidiques et leurs procédés de fabrication et d'utilisation |
| US20250090537A1 (en) | 2023-08-31 | 2025-03-20 | Gilead Sciences, Inc. | Antiviral compounds and methods of making and using the same |
| CN121693506A (zh) | 2023-08-31 | 2026-03-17 | 吉利德科学公司 | 抗病毒化合物及其制备和使用方法 |
| WO2025054278A1 (fr) | 2023-09-06 | 2025-03-13 | Gilead Sciences, Inc. | Formes solides d'un analogue de nucléoside et leurs utilisations |
| US20250109157A1 (en) | 2023-09-28 | 2025-04-03 | Gilead Sciences, Inc. | Compounds and methods for treatment of viral infections |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2734904A (en) * | 1956-02-14 | Xcxnhxc-nh | ||
| US4251545A (en) * | 1979-09-19 | 1981-02-17 | Gaf Corporation | Fungicidal process using 1-(alkoxyaroyl)guanidines |
| US4544670A (en) * | 1982-08-24 | 1985-10-01 | William H. Rorer, Inc. | Method of treating coccidiosis with acyl guanidines |
| JPH0218632A (ja) | 1988-07-07 | 1990-01-22 | Matsushita Electric Ind Co Ltd | 論理ゲート評価装置と論理ゲート評価方法 |
| DE3929582A1 (de) | 1989-09-06 | 1991-03-07 | Hoechst Ag | Benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament sowie sie enthaltendes medikament |
| IL109570A0 (en) | 1993-05-17 | 1994-08-26 | Fujisawa Pharmaceutical Co | Guanidine derivatives, pharmaceutical compositions containing the same and processes for the preparation thereof |
| DE4328869A1 (de) | 1993-08-27 | 1995-03-02 | Hoechst Ag | Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE4421536A1 (de) | 1994-06-20 | 1995-12-21 | Hoechst Ag | Perfluoralkylgruppen tragende phenylsubstituierte Alkenylcarbonsäure-guanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| JPH08225513A (ja) | 1994-12-21 | 1996-09-03 | Kanebo Ltd | ナフトイルグアニジン誘導体 |
| DE19518796A1 (de) | 1995-05-22 | 1996-11-28 | Hoechst Ag | Fluorphenylsubstituierte Alkenylcarbonsäure-guanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE19527305A1 (de) | 1995-07-26 | 1997-01-30 | Hoechst Ag | Substituierte Zimtsäureguanidide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE19606355A1 (de) * | 1996-02-12 | 1997-08-14 | Schering Ag | Kontrazeptive Freisetzungssysteme mit antiviraler und/oder antibakterieller Wirkung |
| DE19621483A1 (de) * | 1996-05-29 | 1997-12-04 | Hoechst Ag | Substituierte 2-Naphthoylguanidine, Verfahren zur ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| AUPO545297A0 (en) | 1997-03-04 | 1997-03-27 | Fujisawa Pharmaceutical Co., Ltd. | Guanidine derivatives |
| US20030113352A1 (en) * | 2001-12-14 | 2003-06-19 | The Regents Of The University Of California | Neutralization of stratum corneum to treat hyperkeratotic skin lesions |
| WO2004056180A1 (fr) * | 2002-12-23 | 2004-07-08 | Global Cardiac Solutions Pty Ltd | Preconditionnement, retention, protection, conservation et recuperation d'organes (1) |
| KR20120045062A (ko) * | 2003-03-31 | 2012-05-08 | 가부시키가이샤 아루떼꾸 우에노 | 혈관 과투과 질환의 치료방법 |
| BRPI0411900B8 (pt) | 2003-06-26 | 2021-05-25 | Biotron Ltd | compostos e composições farmacêuticas compreendendo os mesmos |
| US20070099968A1 (en) | 2004-06-26 | 2007-05-03 | Biotron Limited | Antiviral compounds and methods |
| PT2826770T (pt) * | 2005-06-24 | 2018-12-18 | Biotron Ltd | Compostos acilguanidinas com atividade antiviral |
| CN101287702A (zh) * | 2005-10-19 | 2008-10-15 | 弗·哈夫曼-拉罗切有限公司 | N-苯基苯乙酰胺非核苷逆转录酶抑制剂 |
| JP5727842B2 (ja) | 2011-04-12 | 2015-06-03 | 日野自動車株式会社 | 車両のインストルメントパネル構造 |
| KR101331921B1 (ko) * | 2013-01-16 | 2013-11-21 | 에스케이플래닛 주식회사 | 영유아의 안전을 위한 스마트 인터랙션 서비스를 제공하는 장치 및 방법, 이를 이용한 시스템 |
-
2006
- 2006-06-23 PT PT13197255T patent/PT2826770T/pt unknown
- 2006-06-23 CA CA2612403A patent/CA2612403C/fr active Active
- 2006-06-23 BR BRPI0612309A patent/BRPI0612309B8/pt active IP Right Grant
- 2006-06-23 US US11/922,281 patent/US8669280B2/en active Active
- 2006-06-23 ES ES06741271.8T patent/ES2491217T3/es active Active
- 2006-06-23 JP JP2008517277A patent/JP5373392B2/ja active Active
- 2006-06-23 NZ NZ596107A patent/NZ596107A/xx not_active IP Right Cessation
- 2006-06-23 NZ NZ564398A patent/NZ564398A/en unknown
- 2006-06-23 EP EP06741271.8A patent/EP1902017B1/fr active Active
- 2006-06-23 KR KR1020087001886A patent/KR101419327B1/ko active Active
- 2006-06-23 SG SG201004454-3A patent/SG163517A1/en unknown
- 2006-06-23 BR BR122020006906A patent/BR122020006906B8/pt active IP Right Grant
- 2006-06-23 ES ES13197255T patent/ES2710662T3/es active Active
- 2006-06-23 CN CN201310097430.5A patent/CN103274970B/zh not_active Expired - Fee Related
- 2006-06-23 EP EP13197255.6A patent/EP2826770B1/fr active Active
- 2006-06-23 CN CN2006800226410A patent/CN101208297B/zh active Active
- 2006-06-23 PL PL13197255T patent/PL2826770T3/pl unknown
- 2006-06-23 DK DK13197255.6T patent/DK2826770T3/en active
- 2006-06-23 ZA ZA200800256A patent/ZA200800256B/xx unknown
- 2006-06-23 DK DK06741271.8T patent/DK1902017T3/da active
- 2006-06-23 NZ NZ610715A patent/NZ610715A/en not_active IP Right Cessation
- 2006-06-23 WO PCT/AU2006/000880 patent/WO2006135978A1/fr not_active Ceased
- 2006-06-23 PL PL06741271T patent/PL1902017T3/pl unknown
- 2006-06-23 AU AU2006261593A patent/AU2006261593B2/en active Active
- 2006-06-23 KR KR1020147010199A patent/KR20140072101A/ko not_active Ceased
- 2006-06-23 PT PT67412718T patent/PT1902017E/pt unknown
-
2012
- 2012-09-24 JP JP2012209126A patent/JP5616410B2/ja not_active Expired - Fee Related
-
2013
- 2013-11-05 US US14/071,870 patent/US9440926B2/en active Active
-
2016
- 2016-09-12 US US15/262,075 patent/US10683263B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUS2100051I1 (hu) | Kompozíciók és eljárások sejtproliferációs rendellenességek kezelésére | |
| BRPI0612309B8 (pt) | compostos e composições farmacêuticas antivirais | |
| SG151327A1 (en) | Deazapurines useful as inhibitors of janus kinases | |
| ZA200702322B (en) | Compositions and methods for the diagnosis and treatment of tumor | |
| SG170828A1 (en) | Deazapurines useful as inhibitors of janus kinases | |
| MX2007016324A (es) | Inhibidores hcv. | |
| WO2007001851A3 (fr) | Préparations et méthodes pour le diagnostic et le traitement d'une tumeur | |
| TW200738741A (en) | Antiviral compounds | |
| TW200738742A (en) | Antiviral compounds | |
| MY144616A (en) | Substituted dihydroquinazolines | |
| TNSN06228A1 (en) | Compounds and methods of use | |
| TW200626157A (en) | HCV inhibiting bi-cyclic pyrimidines | |
| MXPA06011327A (es) | Azaindoles utiles como inhibidores de jak y otras proteinas cinasas. | |
| MY142988A (en) | Novel aminobenzophenone compounds | |
| IL187382A0 (en) | Bicyclic derivatives as modulators of ion channels | |
| GB0625648D0 (en) | Compounds | |
| MX2009010127A (es) | Compuestos utiles como inhibidores de janus cinasas. | |
| MY149606A (en) | Therapeutic compositions comprising hyaluronan and therapeutic antibodies as well as methods of treatment | |
| ATE534652T1 (de) | Phosphono-pent-2-en-1-yl-nukleoside und analoga | |
| TN2011000204A1 (en) | Cycloundecadepsipeptide compounds and use of said compounds as a medicament | |
| UA90698C2 (en) | Triazole substituted aminobenzophenone compounds | |
| NO20074780L (no) | Heterocyklylamidsubstituerte imidazoler | |
| MX2013004906A (es) | Nuevos inhibidores especificos de la proteasa ns3 de hcv. | |
| WO2005117939A3 (fr) | Utilisation de ligands gpcr54 pour le traitement de l'infertilite | |
| TW200621799A (en) | Acylated nonadepsipeptides II |